ADMA Biologics, Inc. (ADMA)
16.38
-0.05
(-0.30%)
USD |
NASDAQ |
Feb 09, 16:00
16.38
0.00 (0.00%)
After-Hours: 16:41
ADMA Biologics Market Cap : 3.898B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcutis Biotherapeutics, Inc. | 3.290B |
| Marker Therapeutics, Inc. | 24.68M |
| CorMedix, Inc. | 597.22M |
| Editas Medicine, Inc. | 176.20M |
| Savara, Inc. | 1.062B |
Market Cap Related Metrics
| PE Ratio | 19.24 |
| PS Ratio | 8.246 |
| PEG Ratio | 0.0924 |
| Price to Book Value | 9.041 |
| Price to Free Cash Flow | 99.21 |
| Price | 16.38 |
| Earnings Yield | 5.20% |
| PEGY Ratio | 0.0924 |
| Operating PE Ratio | 24.12 |
| Normalized PE Ratio | 18.95 |